Amarin Corp Plc (AMRN)

[ralphey]

https://www.marketbeat.com/instant-alerts/nasdaq-amrn-analyst-earnings-estimates-2022-01-2-3/


Amarin Co. plc (NASDAQ:AMRN) - Equities research analysts at Jefferies Financial Group raised their Q4 2021 earnings per share estimates for Amarin in a report issued on Friday, January 21st. Jefferies Financial Group analyst M. Yee now expects that the biopharmaceutical company will post earnings per share of $0.00 for the quarter, up from their previous estimate of ($0.01).

A number of other brokerages have also recently weighed in on AMRN. Zacks Investment Research raised shares of Amarin from a "hold" rating to a "strong-buy" rating and set a $4.00 price target on the stock in a research report on Wednesday, January 12th. SVB Leerink restated a "buy" rating and set a $12.00 price objective on shares of Amarin in a research note on Sunday, September 26th. One investment analyst has rated the stock with a sell rating, three have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Amarin currently has an average rating of "Buy" and an average target price of $8.20.